RECOMBINANT ADENO-ASSOCIATED VECTORS FOR TARGETED TREATMENT
    9.
    发明申请
    RECOMBINANT ADENO-ASSOCIATED VECTORS FOR TARGETED TREATMENT 有权
    用于靶向治疗的重组腺相关载体

    公开(公告)号:US20170073703A1

    公开(公告)日:2017-03-16

    申请号:US15337499

    申请日:2016-10-28

    Applicant: CITY OF HOPE

    Abstract: Novel adeno-associated virus (AAV) vectors in nucleotide and amino acid forms and uses thereof are provided. The isolates show specific tropism for certain target tissues, such as blood stem cells, liver, heart and joint tissue, and may be used to transduce stem cells for introduction of genes of interest into the target tissues. Certain of the vectors are able to cross tightly controlled biological junctions, such as the blood-brain barrier, which open up additional novel uses and target organs for the vectors, providing for additional methods of gene therapy and drug delivery.

    Abstract translation: 提供了核苷酸和氨基酸形式的新型腺相关病毒(AAV)载体及其用途。 分离物显示某些靶组织如血液干细胞,肝脏,心脏和关节组织的特异性向性,并且可用于转导干细胞以将目标组织中感兴趣的基因引入。 某些载体能够交叉紧密控制的生物结,例如血脑屏障,其开启额外的新用途和用于载体的靶器官,提供基因治疗和药物递送的其它方法。

Patent Agency Ranking